Yongzhong W.
- Country
- Denmark
- Department
- Hjertemedicinsk Klinik
Research Overview
- A Randomized, Placebo‑Controlled Trial of Zenagamtide (NNC0487‑0111) in Obese Patients with HFpEF or HFmrEF to Reduce CV Death and HF Hospitalization
- Comparison of Continuous Intravenous Infusion versus Intermittent Bolus Administration of Furosemide for Diuretic Efficiency in Patients with Acute Heart Failure
- Evaluation of Mavacamten in Adults with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy: A Randomized, Double-blind, Placebo-controlled Study
Data & Insights
Has run more than one trial at 21 of 302 partner sites.
Specializations
Cardiovascular Research
The investigator specializes in studying treatment approaches for hypertrophic cardiomyopathy, particularly focusing on non-obstructive variants of this cardiac condition.
- Cardiac Muscle Disorders
- Heart Function Assessment
- Exercise Capacity Evaluation
Their research encompasses the evaluation of novel therapeutic agents targeting cardiac muscle functionality and patient health status improvement.
Patient-Centered Outcomes
The investigator focuses on measuring patient-reported health outcomes and physical limitations in cardiovascular conditions.
- Symptom Assessment
- Quality of Life Measures
- Physical Performance Metrics
Their work integrates objective clinical measurements with patient-reported experiences in cardiovascular disease management.
Clinical Assessment Methods
The investigator specializes in exercise capacity evaluation and its relationship to cardiac function in patients with cardiomyopathy.
- Performance Testing
- Functional Capacity Assessment
- Long-term Treatment Outcomes
Their research methodology incorporates extended observation periods to evaluate therapeutic effectiveness in cardiac conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.